Assessing the postdeployment quality of treatment for substance use disorders among Army enlisted soldiers in the Military Health System.

Journal of Substance Abuse Treatment
Rachel Sayko AdamsMary Jo Larson

Abstract

Little is known about the rates and predictors of substance use treatment received in the Military Health System among Army soldiers diagnosed with a postdeployment substance use disorder (SUD). We used data from the Substance Use and Psychological Injury Combat study to determine the proportion of active duty (n = 338,708) and National Guard/Reserve (n = 178,801) enlisted soldiers returning from an Afghanistan/Iraq deployment in fiscal years 2008 to 2011 who had an SUD diagnosis in the first 150 days postdeployment. Among soldiers diagnosed with an SUD, we examined the rates and predictors of substance use treatment initiation and engagement according to the Healthcare Effectiveness Data and Information Set criteria. In the first 150 days postdeployment 3.3% of active duty soldiers and 1.0% of National Guard/Reserve soldiers were diagnosed with an SUD. Active duty soldiers were more likely to initiate and engage in substance use treatment than National Guard/Reserve soldiers, yet overall, engagement rates were low (25.0% and 15.7%, respectively). Soldiers were more likely to engage in treatment if they received their index diagnosis in a specialty behavioral health setting. Efforts to improve substance use treatment in the Mil...Continue Reading

References

Aug 11, 2006·Pain Medicine : the Official Journal of the American Academy of Pain Medicine·Ronald J GirondaRobyn L Walker
Apr 3, 2007·Journal of Substance Abuse Treatment·Alex H S HarrisJohn W Finney
May 26, 2007·Journal of Substance Abuse Treatment·Deborah W GarnickMark Reynolds
Nov 15, 2007·JAMA : the Journal of the American Medical Association·Charles S MillikenCharles W Hoge
Aug 14, 2008·JAMA : the Journal of the American Medical Association·Isabel G JacobsonNicole S Bell
Sep 5, 2008·The Journal of Behavioral Health Services & Research·Alex H S HarrisJohn W Finney
Feb 14, 2009·American Journal of Preventive Medicine·Mandy A StahreTimothy S Naimi
May 7, 2009·Pain Medicine : the Official Journal of the American Academy of Pain Medicine·Michael E ClarkRonald J Gironda
Jun 2, 2010·Psychiatric Services : a Journal of the American Psychiatric Association·Patcho N SantiagoCharles W Hoge
Dec 9, 2010·Journal of Studies on Alcohol and Drugs·Christopher SperaMilton H Cambridge
Mar 8, 2011·Addictive Behaviors·Mark J MattikoRobert M Bray
Apr 13, 2012·Journal of Social Work Practice in the Addictions·Mary Jo LarsonElizabeth L Merrick
May 21, 2013·The Journal of Behavioral Health Services & Research·Robert DuniganGrant A Ritter
Jul 16, 2013·Psychiatric Services : a Journal of the American Psychiatric Association·Katharine A BradleyDaniel R Kivlahan
Nov 19, 2013·Journal of Substance Abuse Treatment·Deborah W GarnickDavid Wright
Jun 13, 2014·American Journal of Public Health·Mary Jo LarsonThomas V Williams
Mar 10, 2016·Journal of General Internal Medicine·Alex H S HarrisMegan E Vanneman
Jul 22, 2017·Journal of Studies on Alcohol and Drugs·Susan M PaddockKatherine E Watkins
Jan 25, 2019·Substance Abuse : Official Publication of the Association for Medical Education and Research in Substance Abuse·Constance WeisnerAndrea H Kline-Simon

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.

© 2022 Meta ULC. All rights reserved